Cargando…
Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017586/ https://www.ncbi.nlm.nih.gov/pubmed/33508207 http://dx.doi.org/10.1164/rccm.202012-4511LE |
_version_ | 1783674079504498688 |
---|---|
author | Foer, Dinah Beeler, Patrick E. Cui, Jing Karlson, Elizabeth W. Bates, David W. |
author_facet | Foer, Dinah Beeler, Patrick E. Cui, Jing Karlson, Elizabeth W. Bates, David W. |
author_sort | Foer, Dinah |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8017586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | American Thoracic Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-80175862021-04-02 Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes Foer, Dinah Beeler, Patrick E. Cui, Jing Karlson, Elizabeth W. Bates, David W. Am J Respir Crit Care Med Correspondence American Thoracic Society 2021-04-01 2021-04-01 /pmc/articles/PMC8017586/ /pubmed/33508207 http://dx.doi.org/10.1164/rccm.202012-4511LE Text en Copyright © 2021 by the American Thoracic Society https://creativecommons.org/licenses/by-nc-nd/4.0/This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ). For commercial usage and reprints, please contact Diane Gern (dgern@thoracic.org). |
spellingShingle | Correspondence Foer, Dinah Beeler, Patrick E. Cui, Jing Karlson, Elizabeth W. Bates, David W. Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes |
title | Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes |
title_full | Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes |
title_fullStr | Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes |
title_full_unstemmed | Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes |
title_short | Reply to Watchorn et al.: Asthma Exacerbations in Individuals on Glucagon-like Peptide-1 Receptor Agonists for Type 2 Diabetes |
title_sort | reply to watchorn et al.: asthma exacerbations in individuals on glucagon-like peptide-1 receptor agonists for type 2 diabetes |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017586/ https://www.ncbi.nlm.nih.gov/pubmed/33508207 http://dx.doi.org/10.1164/rccm.202012-4511LE |
work_keys_str_mv | AT foerdinah replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes AT beelerpatricke replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes AT cuijing replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes AT karlsonelizabethw replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes AT batesdavidw replytowatchornetalasthmaexacerbationsinindividualsonglucagonlikepeptide1receptoragonistsfortype2diabetes |